Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01XOther antineoplastic agents
- Chemical subgroupL01XK
- Chemical substanceL01XK01Olaparib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 5 registrations
- Lynparza 100 MG Comprimidos Recubiertos con Pelicula100 mg · comprimido recubierto con película · Astrazeneca Ab · Marketed
- Lynparza 100 MG Comprimidos Recubiertos con Pelicula100 mg · comprimido recubierto con película · Astrazeneca Ab · Authorised · 2 entries
- Lynparza 150 MG Comprimidos Recubiertos con Pelicula150 mg · comprimido recubierto con película · Astrazeneca Ab
Serbia
ALIMS · 4 registrations
At a glance
- ATC code
- L01XK01
- Registers
- 10
- Historical lists
- 2
- Registrations
- 30
- With their own page
- 22
- Companies
- 11
All medicines with Olaparib
Human medicines from every register that match Olaparib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
30 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| olaparibe | Brazil | Authorised | Natcofarma do Brasil Ltda | ||
| Lynparza | United States | 100MG, 150MG | tablet | Marketed | Astrazeneca |
| Lynparza | United States | 50MG | capsule | Not marketed | Astrazeneca |
| Lynparza | European Union | Authorised | AstraZeneca AB | ||
| Lynparza 100 MG Comprimidos Recubiertos con Pelicula | Spain | 100 mg | comprimido recubierto con película | Marketed | Astrazeneca Ab |
| Lynparza 150 MG Comprimidos Recubiertos con Pelicula | Spain | 150 mg | comprimido recubierto con película | Marketed | Astrazeneca Ab |
| Lynparza 100 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | AstraZeneca AB (Kvarnbergagatan) | |
| Lynparza 150 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | AstraZeneca AB (Kvarnbergagatan) | |
| Lynparza 100 MG Comprimidos Recubiertos con Pelicula | Spain | 100 mg | comprimido recubierto con película | Authorised | Astrazeneca Ab |
| Lynparza 100 MG Comprimidos Recubiertos con Pelicula | Spain | 100 mg | comprimido recubierto con película | Authorised | Astrazeneca Ab |
| Lynparza | Canada | 150 MG | Tablet | Marketed | Astrazeneca Canada INC |
| Lynparza | Canada | 100 MG | Tablet | Marketed | Astrazeneca Canada INC |
| Lynparza® | Serbia | 100mg | film tableta | Authorised | PredstavniŠTvo Astrazeneca UK Limited Beograd |
| Lynparza® | Serbia | 150mg | film tableta | Authorised | PredstavniŠTvo Astrazeneca UK Limited Beograd |
| Lynparza® | Serbia | 150mg | film tableta | Authorised | PredstavniŠTvo Astrazeneca UK Limited Beograd |
| Lynparza® | Serbia | 100mg | film tableta | Authorised | PredstavniŠTvo Astrazeneca UK Limited Beograd |
| Lynparza comprimidos | Brazil | Authorised | Astrazeneca do Brasil Ltda | ||
| Lynparza Film-Coated Tablet 100MG | Singapore | 100mg | tablet, film coated | Authorised | Astrazeneca Singapore Pte LTD |
| Lynparza Film-Coated Tablet 150MG | Singapore | 150mg | tablet, film coated | Authorised | Astrazeneca Singapore Pte LTD |
| Lynparza | Croatia | Marketed | |||
| Lynparza | New Zealand | Tab 150 mg | Funded | ||
| Lynparza | New Zealand | Tab 100 mg | Funded | ||
| Lynparza | Saudi Arabia | Authorised | AbbVie Limited | ||
| LYNPARZA 50 mg Capsule | Saudi Arabia | Authorised | Patheon Manufacturing Services LLC | ||
| Olaparib | United States | 150MG | tablet | Tentative approval | Sandoz INC |
